Tyrosine kinase inhibitors, nilotinib and radotinib, suppress both catalytic function and mRNA expression of human cytochrome P450 2J2 and 2C8

Drug Metabolism and Pharmacokinetics · Published 2025-08-29 · DOI 10.1016/j.dmpk.2025.101501

Authors being retrieved — see the publisher record. https://doi.org/10.1016/j.dmpk.2025.101501

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2025

Related articles